HIPERPROLACTINEMIA ARTICULO PDF

Increased body weight associated with prolactin secreting pituitary adenomas: weight loss with normalization of prolactin levels. Clin Endocrinol (Oxf), 48 () . La presencia de macroprolactina sérica es un hecho relativamente frecuente que puede conducir a exploraciones costosas y tratamientos ineficaces. Manejo terapéutico de la hiperprolactinemia. Therapeutic management of hyperprolactinemia. Visits. J M. Cabezas Agrícolaa, J. Cabezas-Cerratoa.

Author: Akinor Maujinn
Country: Gabon
Language: English (Spanish)
Genre: Travel
Published (Last): 5 February 2016
Pages: 370
PDF File Size: 11.77 Mb
ePub File Size: 2.40 Mb
ISBN: 303-7-72778-664-3
Downloads: 73678
Price: Free* [*Free Regsitration Required]
Uploader: Maugor

It is important to run thyroid function test and to investigate the manifestation of clinical and subclinical hypothyroidism and to initiate treatment with levothyroxine. The osteoporosis in escleroderma is multifactorial ischemia, immobilization, intestinal malabsorption syndrome, steroids, menopause, hyperprolactinemia, among other.

It is important to erform bone densitometry in these patients and to identify the cases of osteoporosis and to start opportune treatment.

Hipperprolactinemia alterations in systemic sclerosis. Olga Lidia Vera-Lastra a ,?? Departamento de Medicina Interna. Hospital de Especialidades Dr. It is important to run thyroid function test and to investigate the manifestation of clinical and subclinical hypothyroidism and to initiate treatment with levothyroxine. It is important to erform bone densitometry in these patients and to identify the cases of osteoporosis and to start opportune treatment.

Textbook of Rheumatology, 5. Med Int Mex, 22pp. Epidemiology and natural history of systemic sclerosis. Rheum Dis Clin North Am, 16pp. Am Heart J,pp. Dehydroepiandrosterone sulphate serum levels in systemic sclerosis. Qrticulo Exp Rheumatol, 19pp. Clin Exp Rheumatol, 18pp. High prolactin and low dehidro-epiandrosterone sulphate serum levels in patients with severe hiperprolactjnemia sclerosis.

  GLASUL ROTILOR TREN PDF

Br J Rheumatol, 36pp. Hiperprklactinemia synthesis by lymphocytes from patients with systemic sclerosis. Biomed Pharmacother, 60pp. Postepy Hig Med Dosw, 60pp. Selective stimulation of collagen synthesis in the presence of co-stimulatory insulin signalling by connective tissue hiperprolactinemi factor in scleroderma fibroblasts.

Arthritis Rheum, 48pp. Peptides, 23pp. Pathologic observations in systemic sclerosis scleroderma. A study of fifty-eight autopsy cases and fifty-eight matched controls.

Am J Med, 46pp. Thyroid disease in progressive systemic sclerosis: Ann Intern Med, 95pp. Prospective evaluation of thyroid function in patients with systemic sclerosis scleroderma.

J Rheumatol, 13pp. Thyroid disease in progressive systemic sclerosis. Rev Med Chil,pp.

Medicina B Aires64pp. Anti-thyroid huperprolactinemia in Italian scleroderma patients: Clin Exp Rheumatol, 15pp. Prevalence of subclinic thyroid disease in mexican systemic sclerosis patients.

J Rheumatol, 33pp. Thyroid dysfunction in a prospectively followed series of patients with hipperprolactinemia systemic sclerosis. J Endocrinol Invest, 13pp. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol, 25pp. Chronic autoimmune thyroiditis and rheumatic manifestations. Joint Bone Spine, 71pp. A case of progressive systemic sclerosis PSS with silent thyroiditis and anti-bovine thyrotropin antibodies.

Endocrinol Jpn, 38pp.

[Current diagnosis and treatment of hyperprolactinemia].

Med Clin Barc73pp. Thyroid function, autoimmune thyroiditis and celiac disease in juvenile idiopathic arthritis. Rheumatology Oxford44pp. Clin Exp Rheumatol, 23pp. Prolactin and thyroid hormones in patients with systemic sclerosis: Z Rheumatol, 61hiperprolactinemis. Ramiro M, Halabe J, editores. McGraw-Hill Interamericana; [en prensa].

Alteraciones endocrinas en la esclerosis sistémica | Reumatología Clínica

Medicina Interna en la Mujer, pp. Replacement therapy with levothyroxine plus triiodothyronine bioavailable molar ratio Clin Endocrinol, 60pp. Am Fam Physician, 72pp. JAMA,pp. L-tiroxine therapy in subclinical hypothyroidism. Ann Intern Med,pp. Circulating lipids and minor abnormalities of thyroid function. Clin Endocrinol Oxf37pp. Thyroid functions and serum lipids in older women: Am J Med,pp. Arch Intern Med,pp. Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: J Clin Endocrinol Metab, 89pp.

  AIA A141 PDF

Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: Effects of subclinical thyroid dysfunction on the heart. Suclinical hypothyroidism and risk of heart failure, other cardiovascular events, and death.

Arc Unt Hiperprolactihemia, 28pp. N Engl J Med,articilo. One hormone or two?. Curr Opin Rheumatol, 3pp.

Postgrad Med J, 68pp. Scleroderma with anomalies of the thyroid function. Ann Med Interne Paris, pp. Ann Dermatol Venereol,pp. Arch Internn Med,pp. Autoinmunity Rev, 1pp. Impared hypothalamic function, prolactinomas, and autoimmune diseases. Arrticulo diurnal rhythm of prolactin in systemic sclerosis.

J Rheumatol, 27pp. High level of prolactin in patients with systemic sclerosis. Clin Rheumatol, aeticulopp. Functional hyperprolactinemia and hypophyseal microadenoma in systemic sclerosis. Diagnosis, hiperprllactinemia and treatment of osteoporosis.

Rheum Dis Clin North Am, 20pp. Bone mineral content in systemic sclerosis measured by photonabsorptiometry. Acta Derm Venereol, 63pp. Osteopenia in systemic sclerosis: Clin Rheum, 10pp. Sem Arthritis Rheum, 34pp. Osteoporosis — less than expected in patients with scleroderma. Rheumatology, 38pp. Prevalencia de osteoporosis en pacientes mexicanos con esclerodermia.

Rev Mex Reumatol, 17pp.